Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 19, 2026	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Market Cap	23	9	5	8	9	3
Market Cap Growth	-3.52%	70.79%	-34.31%	-11.82%	221.01%	-41.95%
Enterprise Value	22.31	8.94	5.35	8.07	8.38	3.11
Last Close Price	0.13	0.07	0.04	0.07	0.09	0.04
PE Ratio	-	-6.50	-4.00	-3.50	-4.50	-2.00
PB Ratio	16.09	20.15	3.70	5.52	4.81	9.32
P/TBV Ratio	14.05	19.88	3.64	5.15	4.47	9.21
P/FCF Ratio	-	-29.99	-5.35	-4.69	-5.49	-10.49
P/OCF Ratio	-	-29.99	-5.35	-4.70	-5.56	-10.49
EV/EBITDA Ratio	-	-5.24	-3.83	-4.62	-4.10	-3.11
EV/EBIT Ratio	-	-5.24	-3.82	-4.59	-4.08	-3.10
EV/FCF Ratio	-8.25	-29.57	-5.39	-4.69	-5.02	-11.41
Debt / Equity Ratio	0.03	0.09	0.03	0.02	0.01	0.83
Debt / EBITDA Ratio	-0.01	-0.02	-0.03	-0.01	-0.02	-0.27
Debt / FCF Ratio	-0.02	-0.13	-0.04	-0.01	-0.02	-0.99
Net Debt / Equity Ratio	-0.63	-0.28	0.03	0.00	-0.40	0.87
Net Debt / EBITDA Ratio	0.27	0.07	-0.03	0.00	0.38	-0.27
Net Debt / FCF Ratio	0.37	0.42	-0.04	0.00	0.46	-0.97
Quick Ratio	0.49	0.10	0.06	0.09	1.38	0.02
Current Ratio	0.58	0.17	0.13	0.27	1.43	0.03
Return on Equity (ROE)	-330.22%	-181.07%	-96.50%	-104.07%	-185.44%	-214.90%
Return on Assets (ROA)	-107.09%	-71.70%	-65.72%	-75.42%	-106.79%	-69.47%
Return on Invested Capital (ROIC)	-522.70%	-171.32%	-94.55%	-133.10%	-230.63%	-134.37%
Return on Capital Employed (ROCE)	-335.94%	-171.26%	-93.49%	-101.93%	-177.57%	-173.03%
Earnings Yield	-13.46%	-15.38%	-25.00%	-28.57%	-22.22%	-50.00%
FCF Yield	-11.65%	-3.33%	-18.67%	-21.30%	-18.22%	-9.54%
Buyback Yield / Dilution	-11.26%	-7.29%	-22.61%	-15.93%	-33.73%	-5.42%

Updated Aug 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.